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Abstract
Pseudo-complementary nucleobases are modified nucleobases which exhibit
normal base pairing with unmodified complementary nucleobases; however, will not
undergo stable base pairing with other pseudo-complementary nucleobases. The pseudocomplementary nature of these bases is of interest for the synthesis of pseudocomplementary peptide nucleic acid (pcPNA) oligomers, which are capable of binding
targets in double-stranded DNA through a double duplex strand invasion. Until recently,
pcPNAs were synthesized via Boc-based oligomerization chemistry which is currently less
popular than the Fmoc-based strategy.
This research describes the development of a Fmoc protected thiouracil PNA
monomer with an acid labile protecting group for use in standard SPPS. The synthesis uses
an orthogonal protection strategy where the nucleobase is deprotected under standard
acidic deprotection and resin cleavage conditions, while oligomerization occurs under
basic conditions.
Keywords:
Peptide nucleic acid, PNA, pseudo-complementary nucleic acid, pcPNA, double duplex
invasion, thiouracil, protecting groups
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Chapter 1: General introduction
1.1. Discovery of DNA
Nuclein, first isolated by Swiss doctor Friedrich Miescher from leukocytes in the
pus on surgical bandages as early as 1868, became one of the most important discoveries
in the fields of biochemistry and chemical biology. While studying the chemical
composition of leukocyte cells, Miescher discovered a precipitate which was resistant to
protease digestion, indicating the novel compound was neither a protein nor a lipid and
was instead a new class of biological molecules.1 Miescher termed his discovery nuclein
due to its extraction from the nucleus of the cells. Miesher’s discovery was later renamed
as ‘nucleic acid’ due to its acidic properties.
In 1909, Phoebus Levene discovered the sugar, phosphate, and nucleobase
components of deoxyribose nucleic acids (DNA), and identified four different
nucleobases: adenine, thymine, cytosine, and guanine.2 However, it was not until the midtwentieth century with foundational discoveries in DNA research that the importance of
nucleic acids in biological chemistry became clear. In 1944, Oswald T. Avery, Colin
MacLeod and Maclyn McCarty proposed that nucleic acids were the carrier of genetic
information, rather than protein which had long been believed.3 Research by Erwin
Chargaff showed that purine and pyrimidine bases exist in a 1:1 ratio, demonstrating that
the number of adenine bases equaled that of thymine and the number of guanine bases
equaled that of cytosine.4-7 Finally, in 1953, working from x-ray analysis by Rosalind
Franklin and Maurice Wilkins, James Watson and Frances Crick proposed the double
helical structure of DNA and the mechanism by which hereditary information is copied. 8
1

1.2. Nucleic acid chemistry
Nucleic acids are an essential component of all known life, with DNA containing
the hereditary information for all prokaryotes and eukaryotes. DNA contains a sugarphosphodiester backbone, composed of β-2-deoxyribose sugars combined by phosphate
at the 3-to-5 hydroxyl of the sugars. Each sugar contains one of four nucleobases adenine,
cytosine, guanine, or thymine attached to the C1 position of the sugar. Nucleic acid
strands can undergo hybridization between complementary base pairs adenine and
thymine, and cytosine and guanine to form a double stranded duplex. The hydrogen
bonding pattern between nucleobases provides specificity of base pairing, with adenine
forming two hydrogen bonds with thymine while cytosine forms three hydrogen bonds
with guanine, preventing mismatched hybridization (Figure 1.1). The duplex is stabilized
due to hydrophobic interactions between the nucleobases and hydrophilic interactions
between the charged phosphate backbone and an aqueous environment, hydrogen
bonding between complementary nucleobases, and π-stacking from the aromatic purine
and pyrimidine nucleobases. Mismatched nucleobases destabilize the duplex,
disfavouring hybridization from occurring, resulting in sequence specificity for strand
hybridization.
The specificity resulting from base complementarity provides a foundation for the
design of nucleic acid oligomers capable of specific hybridization with DNA or RNA targets,
known as molecular probes. This specificity allows the design of nucleic acid probes for
research and genetic screening, as well as potential design of nucleic acid based
therapeutic agents which rely on high specificity targeting of a genetic sequence.
2

Oligonucleotide sequences provide the required specificity through base pairing between
complementary nucleobases. This targeting of a specific genetic sequence can prevent
undesired off-target effects.

Figure 1.1. Base paring between nucleobases A) guanine and cytosine and B) adenine
and thymine
1.3. Modified nucleic acids and DNA analogs
A major limitation to oligodeoxynucleotides (ODNs) used for in vivo applications
results from the chemical instability of nucleic acid strands. ODN strands are susceptible
to hydrolysis by nucleases, enzymes responsible for cleaving phosphodiester bonds in the
breakdown of DNA and RNA, preventing ODNs from reaching the desired target. Many
chemical modifications have been developed to increase the stability of the nucleic acid
oligomers. In many cases, modifications to the sugar-phosphodiester backbone increase
the stability in vivo as it prevents recognition and degradation by nucleases. Modification
such as replacing the phosphate units with analogs such as phosphothioates or
phosphoborates, or replacing the ribose sugar provide resistance to nucleases. However,
these modifications often introduce chiral centers, and reduce the binding affinity
between the oligomer and the target DNA or RNA strand.

3

1.4. Peptide nucleic acid chemistry
One such backbone modification replaces the sugar-phosphodiester backbone
with an aminoethyl glycine backbone with the nucleobases attached via a methylene
carbonyl linker to form a peptide nucleic acid (PNA) (Figure 1.2.).9 The modified backbone
is oligomerized through peptide bonds between a N-terminal amine, and a C-terminal
carboxylic acid to form a PNA oligomer. Advantages of PNAs include, the aminoethyl
glycine backbone maintains natural spacing observed with the sugar-phosphodiester
backbone, allowing normal Watson-Crick base pairing with unmodified DNA, RNA and
PNA strands. The unnatural backbone is resistant to degradation from either nucleases or
proteases as the backbone is not recognized as either an oligonucleotide or a polypeptide
for cleavage. The PNA oligomers undergo more stable hybridization with DNA and RNA
than ODNs due to the neutral aminoethyl glycine backbone, ODNs experience anionic
repulsion due to the negatively charged phosphate groups present in the backbone.
Additionally, due to the neutral backbone, PNA hybridization is independent of ionic
concentrations. PNAs have high sequence specificity for hybridization, with a single base
mismatch significantly destabilizing a PNA-DNA duplex. The aminoethyl glycine backbone
is achiral, allowing for easy synthesis of PNA monomers without difficult purification, and
the amide bonds allow for easy oligomerization using standard solid phase peptide
synthesis (SPPS) techniques.

4

Figure 1.2. Structure of deoxyribose nucleic acid oligomer (DNA), peptide nucleic acid
oligomer (PNA) and amino acid oligomer (peptide)
1.5. Peptide nucleic acids as therapeutic agents and molecular probes
PNA oligomers have potential applications in the design of gene targeting
therapeutic agents. These therapeutic agents typically target a mRNA sequence;
hybridization with the target mRNA inhibits translation preventing protein synthesis,
known as the antisense strategy. Alternatively, gene therapeutic agents can be designed
to specifically recognize and hybridize a target gene, thereby inhibiting transcription and
preventing gene expression (antigene strategy). Studies of PNA oligomers have shown
potential for applications as both antisense and antigene therapeutic agents,
demonstrating the ability to inhibit both translation and transcription.
Antisense inhibition using PNA oligomers has been demonstrated to reduce
translation in in vitro experiments. Inhibition occurs through steric blocking of translation
which occurs either through hybridization overlapping the AUG start codon blocking

5

assembly of the ribosome complex at the start codon or through triplex formation with
the coding region, arresting elongation resulting in the formation of truncated peptide.1012 The

limitation of PNA based antisense therapies is that hybridization with target mRNA

does not activate ribonuclease H (RNase H) -mediated cleavage of the RNA transcript,
which is a more effective method of antisense inhibition. RNase H is an endonuclease
enzyme which cleaves an RNA target using DNA (or a DNA analog) as a template causing
inhibition of mRNA translation.13, 14 RNase H catalyzes the hydrolysis of the target RNA
which is more efficient inhibition compared to steric blocking of the mRNA transcript
which requires a 1:1 ratio of PNA:mRNA to inhibit expression. Unlike some
oligonucleotide analogs such as phosphorothioates,15 PNA:RNA hybridization causes a
structural change which is not recognized by the RNase H enzyme, limiting its
effectiveness as an antisense gene therapy.
Antigene therapies involve the invasion of the DNA duplex using an
oligonucleotide analog to hybridize to the target gene and sterically block the function of
RNA polymerase. In vitro studies suggest that PNA oligomers are capable of inhibiting
transcriptional expression of both prokaryotic and eukaryotic RNA polymerase by
hybridizing to either the gene promoter region or downstream of the promoter blocking
RNA polymerase from accessing the template DNA strand.16,

17

Hybridization to the

promoter region inhibits RNA expression by sterically blocking assembly of the RNA
polymerase complex to the gene, while triplex invasion downstream of the promoter
sterically blocks the progression of RNA polymerase, arresting transcription and resulting
in the formation of truncated RNA transcripts. PNA oligomers have demonstrated
6

potential as antigene therapies, however PNA invasion of a DNA duplex requires the
formation of a PNA2:DNA triplex for invasion to occur limiting targets to homopurine
sequences, which can undergo Watson-Crick and Hoogsteen base pairing. Furthermore,
triplex formation is kinetically slow at physiological salt conditions, limiting PNA2:DNA
triplex hybridization.18
1.6. PNA hybridization
The stability of oligonucleotide duplexes can be determined as a measure of the
thermal stability of the duplex. The thermal melting temperature (Tm) is defined as the
temperature at which 50 % of the oligonucleotide duplex has dissociated. The Tm of
oligonucleotides can be easily measured spectroscopically, due to the hypochromatic
effect observed during hybridization. Free nucleobases absorb strongly around 260 nm,
upon hybridization base pairing causes a reduction in the nucleobase absorbance. 19 This
change in absorbance allows easy determination of Tm values, using absorption
spectroscopy, which is a convenient method of analyzing relative oligonucleotide duplex
stability. Typically, PNA-DNA duplexes have higher Tm values compared to a DNA-DNA
duplex of identical sequence, while a PNA-PNA duplex has a higher Tm than the PNA-DNA
duplex, resulting in a relative duplex stability: PNA-PNA>PNA-DNA>DNA-DNA.
The stability of the PNA-DNA duplex over the DNA-DNA duplex results from
reduced electrostatic repulsion from the neutral aminoethyl glycine backbone, compared
to the phosphate diester backbone. Thermodynamic studies of PNA-PNA and PNA-DNA
hybridization show the lack of charged backbone typically results in more favourable

7

enthalpies of hybridization for the formation of PNA-PNA and PNA-DNA duplexes
compared to the formation of a DNA-DNA duplex. In the case of PNA-DNA hybridization,
a significant entropic contribution results from reduced ion association with the duplex
backbone. The polyanionic phosphodiester backbone of DNA associates with Na + and K+
counterions, while the neutral aminoethyl glycine backbone of PNA does not require
counterions. Therefore, the reduced number of counterions associated with the PNADNA hybrid compared to the DNA-DNA duplex increases the disorder of the system, giving
a more favourable entropic contribution. Circular dichromism (CD) spectroscopy shows
helices formed by PNA-DNA hybridization closely resembles the B-helix formed by DNADNA hybridization suggesting hydrophobic interactions contribute to the stabilization of
the PNA-DNA duplex. In contrast, CD spectroscopy of the PNA-PNA hybridization shows a
rearrangement in the helical structure of the duplex, resulting in a more farourable
enthalpic value, as a result of reduced electrostatic repulsion.18, 20, 21
1.7. DNA strand invasion
A major limitation of PNAs for many biological applications involving gene
targeting is that PNA oligomers do not undergo duplex invasion of a double stranded DNA
duplex. During duplex invasion, the displaced complementary strand remains bound
upstream and downstream of invasion complex, thus the entropic benefit of replacing the
anionic DNA strand with a neutral PNA strand is not obtained which decreases the free
energy of hybridization making strand invasion unfavourable. One method to overcome
this entropic restriction is to hybridize a complementary PNA oligomer to both strands of
the complementary DNA duplex, thereby maximizing the enthalpic contribution from
8

strand hybridization. Lowering the energy of the invaded complex allows duplex invasion
to occur in a process known as a double duplex invasion (Figure 1.3.). However, the
double duplex invasion using PNA oligomers is hindered by the strong hybridization of
PNAs, which results in highly stable PNA-PNA hybridization which is more favourable than
PNA-DNA hybridization. As a result, the use of complementary PNA oligomers in a double
duplex invasion, instead results in the formation of a stable PNA-PNA duplex leaving the
target DNA duplex intact.

Triplex

Triplex Invasion

Duplex Invasion

Double Duplex Invasion

Figure 1.3. Modes of hybridization between PNA oligomer and nucleic acid duplex
A method of destabilizing the PNA-PNA duplex was developed by Nielsen et al22
which utilized modified pseudo-complementary nucleobases to synthesis selectively
binding oligomers, or pseudo-complementary PNAs (pcPNA). Pseudo-complementary
nucleobases (Figure 1.4.), first reported by Gamper et al23 in DNA oligomers, are modified
complementary nucleobases which, when paired with an unmodified complementary

9

nucleobase undergo normal base pairing; however, when combined with another
pseudo-complementary nucleobase steric hinderance prevents normal base pairing. The
pseudo-complementary nucleobases are synthetic analogs of adenine and thymine, 2,4diaminopurine (D) and 2-thiothymine (ST) respectively, which in combination form
pseudo-complementary base pairs. D, an analog of adenine containing an additional
exocyclic amine at the 2 position, undergoes base pairing with thymine forming a more
stable base pairing compared to A:T due to additional hydrogen bonding from the 2
position amine. ST, an analog of thymine which replaces the 2-position carbonyl with a
thiol, undergoes normal base pairing with an unmodified adenine base. D:ST base pairing
is destabilized due to steric hinderance between the 2-position exocyclic amine on D and
the larger sulfur atom which replaces oxygen in ST. Nielsen et al22 reported the first
synthesis of pcPNA oligomers using a boc-based SPPS approach and demonstrated their
ability to undergo a double duplex invasion of a target DNA duplex.

10

Figure 1.4. Base pairing of natural and pseudo-complementary nucleobases A) adenine
and thymine, B) diaminopurine and thymine, C) adenine and thiothymine, D)
diaminopurine and thiothymine
1.8. Solid phase peptide synthesis and protecting group strategy
Two methods of SPPS have primarily been used for chemical oligomerization in
peptide synthesis, which primarily differ in the protecting group strategy. All amino acids
contain both a carboxylic acid and an amine, which undergo a condensation reaction to
form an amide linkage during oligomerization, which must be protected and require
different deprotection conditions for control of sequence specific oligomerization. In
addition, many amino acids contain reactive sidechains which require separate functional
11

group protection. Similarly, PNAs contain both a carboxylic acid and a primary amine
which require separate protection and deprotection strategies, with most nucleobases
requiring further protection during oligomerization. Historically, peptide synthesis was
performed using a gradient acidolysis protection strategy where N-terminal bocdeprotection occurred under relatively weak acidic conditions, while C-terminal
deprotection requires relatively stronger acidic conditions. This strategy for peptide
synthesis was originally developed by Bruce Merrifield using a solid support resin for
peptide synthesis,24, 25 for which he was awarded the 1984 Nobel Prize in chemistry.
Advances in chemical synthesis lead to the development of an orthogonal protection
strategy with N-terminal fmoc group for which deprotection occurs under weakly basic
conditions and C-terminal deprotection occurring under weakly acidic conditions. This
strategy results in higher yielding oligomerization, and as a result can be used to
synthesize longer peptide sequences. Both strategies have been modified for standard
PNA oligomerization, with the standard monomers commercially available for synthesis
The original synthesis of PNA oligomers was reported by Egholm, Buchardt,
Nielsen and Berg in 199226 which utilized a tert-butyloxycarbonyl group on the terminal
amine, while the C-terminus of the oligomer was attached to a solid support, typically a
cross-linked polystyrene resin. The nucleobases were protected using acid labile
protecting groups so oligomer deprotection could occur concurrently with resin cleavage,
under strongly acidic conditions. Thymine requires no protection as it is unreactive under
oligomerization conditions, while the exocyclic amines on cytosine, adenine and guanine
are protected using a carboxybenzyl (cbz) protecting group.9,
12

26, 27

During monomer

synthesis, the C-terminal carbonyl is protected using a alkyl ester protecting group to
prevent coupling between aminoethyl glycine molecules and to improve solubility in
organic solvents.28 The Nα-boc protection is typically removed by treatment with
trifluoroacetic acid (TFA), freeing the N-terminus for oligomerization from C-terminus to
N-terminus. Oligomerization uses a coupling reagent such as hydroxybenzotriazole
(HOBt) and N,N’-dicyclohexylcarbodiimide (DCC) which reacts with the carboxylic acid to
form an active ester for amide bond formation. Post-synthesis treatment of the resin with
hydrofluoric acid (HF) or trifluoromethylsulfonic acid (TFMSA) is used to cleave the
synthesized oligomer from the solid support and to remove the cbz and bn protection of
the nucleobases (Figure 1.5.).

Figure 1.5. SPPS cycle for oligomerization with boc/cbz based protecting strategy
13

The limitation of boc-based peptide synthesis results from the gradient protection
strategy. This can result in undesired cleavage of the PNA oligomer from the solid support
resin, lowering the yield of oligomer synthesis. Low yielding oligomerization limits the
maximum length of oligomer synthesis. Additionally, the final deprotection and resin
cleavage requires strongly acidic treatment with hydrofluoric acid which can damage the
oligomer and the harsh reagents can be dangerous to work with. An orthogonal
protection strategy which uses a fluorenylmethyloxycarbonyl (fmoc) protecting group on
the terminal amine, which requires weakly basic conditions for deprotection. Typical
deprotection conditions use a solution of 20 % v/v piperidine solution in
dimethylformamide to remove the fmoc protection, for oligomerization on the Nterminal (Figure 1.6.). The fmoc protecting group allows the use of more acid labile
protecting groups for the C-terminal and for nucleobase protection. An acid labile linker
is used to attach the polystyrene resin to the C-terminal of the oligomer. Nucleobase
protection uses a more acid labile boc or benzhydryloxycarbonyl (bhoc) group to protect
the exocyclic amines on cytosine, adenine, and guanine allowing resin cleavage and the
final deprotection of the oligomer to be performed using a solution of 95 % v/v
trifluoroacetic acid and 5 % triethylsilane as a cation scavenger. This orthogonal
protection strategy uses milder deprotection conditions, and typically results in higher
yielding oligomerization compared to the boc-based protection strategy. Due to these
advantages, the fmoc-based protection strategy has become the standard for the
chemical synthesis of peptides and PNA oligomers.
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Figure 1.6. SPPS cycle for oligomerization with fmoc/boc based protection strategy
The pcPNA synthesis developed by Nielsen et al utilized the boc-based protection
strategy, which at the time of development was the standard for peptide synthesis.
Advances in peptide synthesis have limited the use of pcPNAs in nucleic acid research due
to the undesirable method of oligomerization. However, several applications have been
developed which demonstrates the potential for pcPNAs and the need for further
research. Until recently,29 only the boc-based SU monomer had been synthesized while
both the boc protected and fmoc protected30 D monomers, therefore the focus of this
research is to synthesize a fmoc protected SU monomer compatible with standard fmocbased SPPS.
15

1.9. Goals of thesis
Until recently, the synthesis of pcPNA oligomers was carried out using boc-based
oligomerization strategy which has become unfavourable due to harsh deprotection
conditions which result in lower yielding reactions thus limiting oligomer length.
Therefore, the primary aim of this work is to develop a highly acid labile protecting group
for thiouracil so that the PNA monomer is compatible with fmoc-based PNA
oligomerization (Figure 1.7.). The 4-methoxybenzyl protecting group first used for bocbased synthesis was reportedly removed upon treatment with TFMSA or HF used for resin
cleavage and final deprotection. To improve the lability of the protecting group, electron
donating groups will be added to the benzyl based protecting group and the acidolysis of
the protecting group tested under milder deprotection conditions.

Figure 1.7. Proposed synthesis of highly acid labile protecting group for thiouracil PNA
monomer
16
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Chapter 2: Highly acid labile S-protection of thiouracil and thiothymine
2.1. Introduction
The oligomerization of peptide nucleic acids (PNAs) was designed based on the
existing standard for peptide synthesis.1 At the time of development, standard solid phase
peptide synthesis (SPPS) utilized gradient acidolysis, with relatively weakly acidic
conditions removing N-terminal amine protection and stronger acidic conditions utilized
for sidechain deprotection and cleavage from the solid support resin. Typically, thymine
and uracil nucleobases do not require protection as there they do not contain nucleophilic
exocyclic amino groups. However, replacing the carbonyl group of T and U with a thionyl
group at the 2 position of the nucleobase creates a nucleophilic site. Unlike with T and U
nucleobases, the thiol at the 2 position of 2-thiouracil (SU) is the most nucleophilic site
due to the greater nucleophilicity of sulfur compared to nitrogen, as a result alkylation of
the unprotected nucleobase with the methylene carbonyl linker results in S-alkylation
rather than the desired N 1-alkylation. Therefore, protection of the SU nucleobases in
necessary due to the nucleophilicity of the thiol group.
Nielsen et al developed the synthesis of a protected thiouracil (SU) compatible
with PNA oligomerization under standard SPPS conditions.2 This synthesis reports a 4methoxybenzyl protecting group on the 2-thiol position of the nucleobase, converting the
thiol (1) to a thioether (2), which is removed under strongly acidic conditions used for
global deprotection. The protected thiouracil nucleobase (3) is then attached to the
protected aminoethyl glycine (AEG) backbone via a methylene carbonyl linker to yield the
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SU

monomer for oligomerization (Scheme 2.1.). The SU monomer is then incorporated

into PNA oligomers using standard boc-based SPPS procedures.

Scheme 2.1. Synthesis of thiouracil PNA monomer compatible with boc-based peptide
synthesis2
Modern SPPS techniques utilize an orthogonal protection system which removes
protecting groups and cleaves the peptide from the solid support resin under milder acidic
conditions. Due to the mild conditions used for global deprotection, this work aims to
develop a more acid labile protecting strategy for the SU monomer which is easily
removed under these conditions. The electron donation from the 4-methoxy substituents
on the benzyl protecting group helps stabilize the carbocation formed from acidolysis of
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the protecting group. We propose that increasing the electron donation into the benzylic
position will increase the stability of the cleaved product (Figure 2.1.). The increased
stabilization of the cationic product results in a more acid labile protecting group which
can be removed under milder acidolysis conditions. This chapter focuses on the
protection of the thiouracil nucleobase using an increased number of methoxy groups on
the aromatic ring to tune the removal of the benzyl protecting group for fmoc-based
synthesis.

Figure 2.1. Mechanism of thiol protecting group acidolysis
2.2. Synthesis
2.2.1. Thiouracil protection with 2,4,6-trimethoxybenzyl group
The 4-methoxybenzyl protecting group used by Nielsen et al., was initially
replaced by a 2,4,6-trimethoxybenzyl group for protection of the thiol group. Synthesis
(Scheme 2.2.) started with 2,4,6-trimethoxybenzaldehyde (7) which was reduced using
sodium borohydride, to yield 2,4,6-trimethoxybenzyl (8) alcohol as the product. The
benzyl alcohol was then halogenated to replace the alcohol group with a good leaving
group for addition onto the thiouracil nucleobase. Initial attempts at halogenation used
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thionyl chloride as a chlorinating agent, however instability of the 2,4,6-trimethoxybenzyl
chloride resulted in rapid decomposition of the intermediate, preventing addition to the
nucleobase. The electron donation from the three methoxy substituents on the benzyl
group greatly increases the electron density at the benzylic position which stabilizes the
carbocation formed from the elimination of the benzylic chloride. However, the electron
donation to the benzylic carbocation allows the rapid decomposition of the 2,4,6trimethoxybenzyl chloride upon workup of the reaction, preventing the isolation of the
desired intermediate for the protection of the thiouracil nucleobase.
To overcome the issue with the workup and isolation of the 2,4,6trimethoxybenzyl chloride from the solution of thionyl chloride, a different chlorination
method was utilized which did not require workup prior to addition of thiouracil. The
2,4,6-trimethoxybenzyl alcohol was added to a solution of triphenylphosphine (Ph3P) and
N-chlorosuccinimide as the chlorinating agent for the 2,4,6-trimethoxybenzyl alcohol. The
solution was then added to a basic solution of thiouracil without workup of the reactive
2,4,6-trimethoxybenzyl chloride intermediate (9). This enabled the synthesis of the 2,4,6trimethoxybenzyl protected SU nucleobase (10), however the reaction resulted in low
yields of the desired product and triphenylphosphine oxide (Ph3PO) was a major
byproduct of the reaction which could not be easily separated from the desired product.
Due to the difficulty in purification, alkylation of the protected thiouracil was performed
using the crude mixture of the nucleobase and Ph3PO. We believed that the
triphenylphosphine oxide would not affect the alkylation of the nucleobase, and that once
alkylated the thiouracil could be easily separated from the triphenylphosphine oxide by
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column chromatography. The crude mixture reacted with methyl bromoacetate as the
alkylating agent in a solution of sodium carbonate in dimethylformamide, and the
resulting product (11) was purified by column chromatography.

Scheme 2.2. Attempted synthesis of 2,4,6-trimethoxybenzyl protected thiouracil
nucleobase
1H

NMR analysis of the purified product indicated addition of the 2,4,6-

trimethoxybenzyl protection to the thiol group, however the 1H NMR spectra also
indicated a loss of symmetry in the protecting group, with the detection of 3 distinct
signals from the methoxy substituents on the aromatic ring. Furthermore, the integration
of the aromatic protons on the benzyl ring decreased from 2 H to 1 H, suggesting a
substitution on the aromatic ring. The low-resolution mass spectra of identified a
compound with a molecular mass of 414.09 amu, which is about 34 amu larger than then
expected mass of the compound (380.10 amu). Based on the mass of the synthesized
compound, and the loss of symmetry in the 2,4,6-trimethoxybenzyl protecting group
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suggest that chlorination of the aromatic ring had occurred in addition to chlorination of
the benzylic carbon. A search of the literature found metal-free electrophilic aromatic
halogenation of electron rich aromatic rings using N-halosuccinimide (NXS) as a
halogenating agent, and catalytic trimethylsilyl chloride (TMSCl).3 The proposed
mechanism for this reaction suggests that a small amount of chloride ions dissociate from
TMSCl and reacts with NXS to form a diatomic interhalogen molecule which acts as the
halogenating agent. This demonstrates the aromatic ring, when activated by electron
donating groups, can undergo halogenation with N-halosuccinimide as a halogenating
agent. Similarly, the highly electron rich aromatic ring of the 2,4,6-trimethoxybenzyl
group undergoes a metal-free electrophilic aromatic halogenation from the Nchlorosuccinimide and triphenylphosphine chlorination conditions.
HMBC NMR analysis of the compound was performed to determine the structure
of the synthesized compound. Three possible constitutional isomers exist from alkylation
of the protected SU nucleobase, with alkylation of either the N-1 position or the N-3
position common with alkylation of uracil and O-alkylation of the carbonyl at the 4position also possible. Analysis of the HMBC NMR spectra looks at interactions between
the methylene carbonyl protons with the carbon atoms of the thiouracil ring. For the
desired N-1 alkylation, the expected interaction would be observed with the C-2 and C-6
atoms while N-3 alkylation would result in interaction between the methylene carbonyl
protons and the C-2 and C-4 atoms. Neither of these outcomes are observed in the HMBC
NMR spectra, instead interactions between the methylene carbonyl protons and the C-4
and C-5 atoms indicating O-alkylation of the thiouracil. Due to the low yield of S-alkylation
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of the thiouracil with the 2,4,6-trimethoxybenzyl protecting group, the subsequent
halogenation of the electron rich aromatic ring of the benzyl group, and the difficulty in
alkylating the N-1 position, a less electron donating group was used for the thiol
protection.
2.2.2. Thiouracil protection with 2,4-dimethoxybenzyl group
The destabilizing effect from the electron donation of the three methoxy groups
into the benzylic carbon on the 2,4,6-trimethoxybenzyl chloride can be reduced by
removing one of the methoxy substituents from the aromatic ring, instead using the 2,4dimethoxybenzyl chloride. However, reducing the electron donation into the benzylic
carbon will reduce the acid lability of the protecting group, as it reduces the stabilization
of the carbocation formed from protecting group acidolysis. The 2,4-dimethoxybenzyl
protecting group was used for protection of the nucleobase, as this would provide a more
stable chloride intermediate than the 2,4,6-trimethoxybenzyl chloride, but would also
provide more electron donation than the 4-methoxybenzyl group allowing easier
acidolysis.
The protected thiouracil nucleobase was synthesized (Scheme 2.3.) starting with
2,4-dimethoxybenzaldehyde (12), which was first reduced using sodium borohydride in
methanol to yield the 2,4-dimethoxybenzyl alcohol (13). The benzyl alcohol is then
halogenated using a solution of thionyl chloride to form 2,4-dimethoxybenzyl chloride
(14). The reaction was quenched using aqueous sodium bicarbonate, then the 2,4dimethoxybenzyl chloride was extracted in ether to yield the compound as a clear
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colourless oil. The 2,4-dimethoxybenzyl group was then added to the thiol group of the
thiouracil

using

triethylamine

as

the

base,

which

yielded

the

2-(2,4-

dimethoxybenzyl)thiouracil (15) as a white solid. The protected thiouracil was then
alkylated using methyl bromoacetate in a solution of sodium methoxide, which yielded a
mixture containing both N-1-alkylation (16) and O-4-alkylation of the nucleobase which
was easily separated by column chromatography. The N-1-alkylated product was
synthesized in just a 22 % yield, while the O-alkylated product resulted in a 13 % yield.
Despite the low yield of the synthesis, the unreacted S-(2,4-dimethoxybenzyl)thiouracil
was easily separated by column chromatography and reacted with methyl bromoacetate
and sodium methoxide in a second alkylation reaction to increase the yield of the desired
N-1-alkylated product.

Scheme 2.3. Synthesis of 2,4-dimethoxybenzyl protected thiouracil nucleobase
The N-1- and O-alkylated constitutional isomers were characterized with 1H NMR
spectroscopy. A comparison of the spectra showed similar chemical shifts with the
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methylene carbonyl proton shifts as the major identifying feature of the constitutional
isomers. The alkylation of the O-4 resulted in a downfield shift in the methylene carbonyl
signals compared to alkylation at the N-1 position. Further HMBC NMR analysis of the
compound suggested N-1 alkylation due to the interaction between the methylene
carbonyl protons and the carbon atoms at the 2 and 5 positions of the pyrimidine ring,
while the O-alkylation product showed coupling between the methylene carbonyl
protons and the C-4 atom on the pyrimidine ring (Figure 2.2.).

Figure 2.2. HMBC NMR interactions of methylene carbonyl protons with pyrimidine ring
carbons when alkylated in the N-1, N-3 and O-4 positions
The acid cleavage of the thiol protecting group was confirmed under standard
deprotection conditions used for global deprotection of PNA oligomers synthesized using
fmoc-based oligomerization. The N-1-alkylated S-(2,4-dimethoxybenzyl)thiouracil was
mixed with a solution of 5 % triethylsilane in trifluoroacetic acid, then the acid was
evaporated under a nitrogen stream then the product was triturated with ether. The 1H
NMR spectra of the obtained product shows removal of the thiol protecting group under
standard deprotecting conditions. The removal of the 2,4-dimethoxybenzyl group is seen
as the absence of the methoxy protons, the aromatic benzyl protons and the benzylic
protons in the NMR spectra. This test confirmed the acid lability of the thiol protecting
group under standard deprotection conditions suggesting that once incorporated into a
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PNA oligomer, using fmoc-based chemistry, the thiouracil nucleobases could be easily
deprotected during the global deprotection and resin cleavage of the PNA oligomer.
2.2.3. Thiouracil protection with 2-methyl-4-methoxybenzyl group
Recently published work reports the synthesis of a thiouracil monomer
compatible with fmoc-based oligomerization conditions using a 2-methyl-4methoxybenzyl group for protection of the nucleobase.4 Electron donation from the
methyl group into the aromatic ring, through hyperconjugation, increased electron
density at the benzylic position which stabilizes the benzylic carbocation. The
hyperconjugation of the methyl group provides weaker electron donation than the
resonance from the methoxy groups; however, the electron donation from the methyl
substituent combines with the electron donation of the para methoxy substituent to
increase electron density at the benzylic position compared to the 4-methoxybenzyl
group. Therefore the 2-methyl-4-methoxybenzyl protected

SU

nucleobase was

synthesized (Scheme 2.4.) following the procedures described by Kittaka et al.4 in order
to test the rate of the protecting group acidolysis compared to the rate of acidolysis of
the newly synthesized 2,4-dimethoxybenzyl protected nucleobase.
The 2-methyl-4-methoxybenzyl aldehyde (17) was reduced to the benzyl alcohol
(18) using sodium borohydride. The alcohol was then substituted with a chloride using
thionyl chloride to yield the 2-methyl-4-methoxybenzyl chloride (19) for the protection of
thiouracil. The benzyl group was added to the thiol group under basic conditions to yield
the S-(2-methyl-4-methoxybenzyl)thiouracil (20) which was N-1 alkylated (21) with ethyl
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bromoacetate using a solution of sodium ethoxide in ethanol. Under these conditions, the
O-alkylated product was formed as the minor product, and the products were easily
separated by column chromatography. 1H NMR analysis of the product matched the
literature spectra reported by Kittaka et al., therefor no further characterization was
performed.4

Scheme 2.4. Synthesis of 2-methyl-4-methoxybenzyl protected thiouracil nucleobase

2.2.4. Thiouracil protection with 4-methoxybenzyl group
To study the effects of the addition of methoxy substituents to the ortho- and
para- positions of the benzene ring on the kinetics of the acidolysis of the benzyl
protecting group from the thiol of the thiouracil nucleobase, the 4-methoxybenzyl
protected thiouracil was synthesized. The 4-methoxybenzyl thiouracil being used in the
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original synthesis of the thiouracil monomer for boc-based oligomerization, it was
synthesized as a comparison for the more highly acid labile thiol protected monomers.
The S-(4-methoxybenzyl)thiouracil was synthesized (Scheme 2.5.) starting with
the 4-methoxybenzyl alcohol (22), which was reduced to the benzyl alcohol (23) using
sodium borohydride. The benzylic alcohol was substituted with chloride using thionyl
chloride, and the resultant 4-methoxybenzyl chloride (24) was added to the thiouracil
under basic conditions to obtain S-(4-methoxybenzyl)thiouracil (2). The protected
nucleobase was then alkylated using ethyl bromoacetate and sodium ethoxide to yield N1 alkylated 4-methoxybenzyl protected thiouracil nucleobase (3). The 1H NMR spectra of
the product matched the literature spectra reported by Nielsen et al.2

Scheme 2.5. Synthesis of 4-methoxybenzyl protected thiouracil nucleobase
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2.2.5. 4-Methoxybenzyl protected thiothymine
Thymine and uracil are nucleobases which differ only in the substituent at the 5position of the pyrimidine ring, and both undergo complementary base pairing with
adenine. To date, only the thiouracil nucleobase has been studied as a pseudocomplementary nucleobase in PNA oligomers; however, pseudo-complementary base
pairing was first demonstrated using thiothymidine as a thymine analog in combination
with 2,4-diaminopurine in oligodeoxynucleotides.5 Studies comparing the melting
temperatures of oligodeoxynucleotides containing either thymine or uracil as the
complementary base with adenine show an increased hybridization stability of
oligodeoxynucleotides containing thymine compared to the stability of those containing
uracil.6 To study to effect of thiothymine on the hybridization stability when incorporated
into pcPNA oligomers, a protected thiothymine monomer was synthesized (Scheme 2.6.).
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Scheme 2.6. Synthesis of 4-methoxybenzyl protected thiothymine nucleobase
Thiothymine was synthesized from the thymine nucleobase by first methylating
the N-1 and N-3 positions (26) of the thymine ring using dimethyl sulfate. The dimethyl
urea moiety was then substituted with thiourea to replace the carbonyl with a thiol (27).
Due to the higher nucleophilicity of sulfur compared to nitrogen, the thiol undergoes
nucleophilic attack of the C-6 position in a Michael addition followed by β-elimination of
the methylated amine. The thiourea then undergoes nucleophilic attack at the C-4
position with elimination of N,N’-dimethylurea to form a 1,3-thiazine ring (Figure 2.3.).7
The 1,3-thiazine undergoes rearrangement to the pyrimidine ring under alkali conditions
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to form thiothymine.8-10 The thiol group of the thiothymine was then protected with 4methoxybenzyl chloride (30) under basic conditions. The nucleobase (31) was then
alkylated with ethyl bromoacetate using sodium ethoxide to yield the N-1 alkylated
product (32) as the major product and the O-alkylated product as the minor product.

Figure 2.3. Mechanism of nucleophilic attack of 1,3-dimethyl thymine by thiourea to
form 1,3-thiazine
2.2.6. Thiouracil and thiothymine PNA monomers
The aminoethylglycine backbone was synthesized (Scheme 2.7.) with a methyl
ester protecting group on the C-terminal carboxylic acid and the fmoc protecting group
on the N-terminal amine. The backbone was previously synthesized as the
dihydrochloride salt following literature procedures, an excess of ethylenediamine was
alkylated with 2-chloroacetic acid, then protected using thionyl chloride and methanol
(34).11, 12 The fmoc group was added to the N-terminus of the methyl aminoethyl glycinate
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using fmoc-succinimide under basic conditions, then the protected backbone was isolated
and stored as the hydrochloride salt (35).13
The alkylacetate of the protected nucleobase (32) was hydrolyzed using a solution
of aqueous lithium hydroxide, to obtain the carboxylic acid functional group (33) for
attachment to the aminoethylglycine backbone. The protected nucleobase was then
reacted with a solution of hexafluorophosphate benzotriazole tetramethyl uroniom
(HBTU) and diisopropylethyl amine (DIPEA), which acts as the coupling agent by forming
an active ester on the methylene carbonyl linker of the nucleobase. The activated
nucleobase is then reacted with the protected aminoethylglycine backbone to form the
PNA monomer (36). The methyl ester protecting the C-terminus of the PNA monomer is
then hydrolyzed using a solution an aqueous lithium hydroxide to form the C-terminus
carboxylic acid (37). The kinetics of the reactivity of the C-terminus protecting group
compared to the N-terminus protecting group under aqueous alkali conditions favours
hydrolysis of the methyl ester rather than removal of the fmoc group, giving selective
deprotection of the PNA backbone.
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Scheme 2.7. Synthesis of thiouracil and thiothymine PNA monomer (37)
Basic conditions to remove the fmoc protecting group uses a solution of 20 %
piperidine (pKa = 11), a weaker base than lithium hydroxide (H2O pKa = 16), however
selectivity for the hydrolysis of the methyl ester is due to faster kinetics of the ester
hydrolysis using a hydroxide base. Amine bases are effective in the removal of the fmoc
group since the acidolysis of the fmoc group results in the formation of highly reactive
dibenzofulvene as a byproduct of the reaction, which is trapped by the amine base to
form stabile adducts. Amine bases such as piperidine effectively trap the dibenzofulvene
intermediate which drives the deprotection reaction to completion.14-16 This driving force
of the reaction is not present using a hydroxide base, which slows the rate of fmoc
deprotection, and kinetically favours hydrolysis of the methyl ester giving selectivity for
deprotection of the C-terminus.
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Hydrolysis of the C-terminus methyl ester yields the desired thiouracil or
thiothymine PNA monomer for oligomerization. The monomers where characterized
using 1H NMR and 13C NMR spectroscopy and high-resolution mass spectrometry (HRMS).
The 1H NMR spectra shows several rotamer structures resulting from the amide bond
formed between the methylene carbonyl linker and the aminoethyl glycine backbone and
resulting from the carbamate resulting from fmoc protection of the N-terminus. The
rotamers result from resonance of the nitrogen electrons into the π-bonding of the amide
group. The greater electronegativity of the oxygen pulls greater electron density, causing
partial π-bonding between the nitrogen and the carbon which prevents free rotation
around the amide bonds. This results in resonance structures with E and Z conformational
isomers from the amide bond and results in major and minor 1H NMR signals for many of
the alkyl protons (Figure 2.4.).

Figure 2.4. Resonance structures from amide and carbamate rotamers of PNA monomer
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2.3. Conclusions
This chapter demonstrates the synthesis of thiouracil and thiothymine
nucleobases with various benzyl based protecting groups (Figure 2.5.) on the 2-position
thiol group. The addition of electron donating functional groups at the ortho- and parapositions of the benzene ring increases the electron density on the benzylic position. The
addition of methoxy substituents onto the ortho- and para- positions donates electron
density to the benzylic position through resonance through the aromatic ring. The next
chapter will investigate the rate of acidolysis of the protecting group under standard
fmoc-based SPPS deprotection conditions. This research aims to develop a highly acid
labile protecting group for the thiol protecting group compared to the paramethoxybenzyl group used for boc-based pcPNA oligomerization. Furthermore, the
deprotection rate was compared to the rate of acidolysis of the recently reported 2methyl-4-methoxybenzyl protecting group developed for fmoc-based synthesis of pcPNA.
Finally, using common coupling conditions the protected nucleobase was attached to the
PNA backbone to synthesize the thiouracil and thiothymine PNA monomer for PNA
oligomerization.

Figure 2.5. Benzyl based protecting groups on thiouracil
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Chapter 3: Deprotection and oligomerization of thiouracil and thiothymine monomers
3.1. Introduction
The Hammett principle describes the linear effects of substituents in the meta and
para positions of a benzene ring on the rate and on the equilibrium of a reaction on a side
chain attached to the aromatic ring.1, 2 The addition of electron donating groups and
electron withdrawing groups to the benzene ring affect the electron density at the
benzylic position. The Hammett principle describes the cumulative effect of electron
donating and withdrawing groups at the meta- and para- position on the rate or
equilibrium of reactions at the benzylic position caused by displacement of electron
density on the aromatic ring. This linear relationship is not maintained with substituents
at the ortho- position of the benzylic ring due to steric and electronic interactions
between the ortho- and benzylic substituents.
The use of the 4-methoxybenzyl protecting group for the protection of the
thiouracil nucleobase for boc-based peptide synthesis demonstrated the cleavage of the
protecting group under treatment with strongly acidic trifluoromethylsulfonic acid. Thus,
to improve the acid lability of the thiol protecting group, electron donating groups were
added to the aromatic ring to push electron density to the benzylic position. The greater
electron density on the benzylic position serves to stabilize the benzylic carbocation
formed from the cleavage of the benzyl based protecting group. Several protected
thiouracil nucleobases were synthesized with benzyl based protecting groups to test the
cleavage of the protecting group under treatment with milder acidic conditions used for
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fmoc-based oligomerization. The addition of methyl and methoxy groups to the aromatic
ring were used to increase electron density on the benzylic position and drive the
acidolysis of the protecting group.
3.2. Results of benzyl based protection acidolysis
The stability of the various methyl and methoxy benzyl protecting groups was
tested under standard deprotection conditions which uses a solution of 95 %
trifluoroacetic acid (TFA) and 5 % triethyl silane which quenches the resulting benzylic
carbocation generated by acidolysis. The deprotection was monitored by 1H NMR and the
integration of the benzylic protons was used to monitor the progression of the reaction,
while the integration of the methylene carbonyl protons was used as a reference for the
integration. A drop of chloroform was added to the TFA solution as a solvent reference
for the NMR spectra.
Initial studies of the deprotection of the 4-methoxybenzyl protected thiouracil
found that rapid acidolysis of the thioether occurred under standard deprotection
conditions. The initial recording of the 1H NMR spectra occurred 4 min after the addition
of the TFA solution to the 4-methoxybenzyl protected thiouracil. The initial spectra
showed complete deprotection of the thiouracil had occurred prior to the initial
measurement, suggesting rapid acidolysis of the thioether was occurring. This study
suggested that the 4-methoxybenzyl protecting group originally developed for boc-based
oligomerization was easily removed under TFA deprotection conditions. Due to the acid
lability of the 4-methoxbyenzyl protecting group upon treatment with TFA, the thiouracil
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protecting group was likely removed during boc-based synthesis of the pcPNA oligomer.
Since this study showed the 4-methoxybenzyl protecting group is removed under the
same deprotection conditions as the N-boc protecting group, the thiouracil protection
was likely cleaved during boc-based oligomerization. This suggests that the thiol
protecting group is not necessary for the oligomerization, and protection of the thiol
group is only necessary for blocking S-alkylation and directing alkylation to the N-1
position.
Due to the high lability of the 4-methoxybenzyl group when treated with standard
deprotection conditions, milder deprotection conditions were used to compare the
relative rates of acidolysis of the benzyl based protecting groups. The acidolysis of the
benzyl protecting groups was tested using solutions containing a lower concentration of
TFA, and the deprotection of the 4-methoxybenzyl group was easily monitored using a
solution of 2 % TFA and 1% triethylsilane in deuterated chloroform. The acidolysis of the
protecting group was monitored by 1H NMR; the integration of the benzylic protons and
the methylene carbonyl protons was measured at 2 min intervals over 2 hours or until
complete deprotection had occurred (Figure 3.1.). The integration of the methylene
carbonyl protons was used as a reference for the integration and was recorded as 2
protons, then the relative integration of the benzylic protons was plotted against the
reaction time. The half-life of the thioether under acidolysis conditions was used to
compare the stability of the benzyl based protecting groups (Figure 3.2.).
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Figure 3.1. 1H NMR spectra of S-(2-methyl-4-methoxybenzyl)thiouracil acidolysis in a
solution of 2 % TFA and 1 % triethylsilane in CDCl3.
Under the 2 % TFA deprotection conditions, the S-(4-methoxybenzyl)thiothymine
and the S-(4-methoxybenzyl)thiouracil deprotected at similar rates, with the deprotection
of thiothymine slightly slower than the deprotection of thiouracil. The slightly higher
stability of the S-(4-methoxybenzyl)thiothymine is likely due to the formation of a more
stable intermediate upon protonation of the nucleobase. The pKa of thymine (9.86) is
slightly higher than that of uracil (9.36) which is likely due to the C-5 methyl group, which
can donate electron density into the pyrimidine ring making thymine a slightly more basic
nucleobase than uracil.3 Similarly, upon treatment with TFA, the electron donation from
the methyl group helps to stabilize the positive charge resulting from protonation of the
nucleobase. The higher stability of the protonated thiothymine compared to the
thiouracil nucleobase results in a slightly slower acidolysis of the thioether. In the case of
both the S-(4-methoxybenzyl)thiouracil and S-(4-methoxybenzyl)thiothymine, the
43

majority of the nucleobase was deprotected after 2 hours when treated with mild
deprotection conditions. This contradicts previous assumptions that strongly acidic
conditions were necessary for the acidolysis of the protecting group, and as a result a
more acid labile thiol protecting group was necessary for adapting the thiouracil PNA
monomer for a standard fmoc-based oligomerization strategy.4,

5

However, this

assumption was never tested and the conditions necessary for acidolysis were not
previously examined. Acidolysis of the S-(2-methyl-4-methoxybenzyl)thiouracil was faster
than the acidolysis of the S-(4-methoxybenzy)thiouracil. The reaction went to completion
within 90 min, and the protected nucleobase had a half-life of around 13 min when
treated with the solution of 2 % TFA (Figure 3.2.). The 2,4-dimethoxybenzyl was the most
acid labile of the protecting groups studied, with complete deprotection of the S-(2,4dimethoxybenzyl)thiouracil occurring within 4 min of treatment with a solution of 2 %
TFA. Since the first 1H NMR measurement was recorded after 4 min of treatment with
TFA, no measurements of the acidolysis were recorded and the half-life of the reaction
could not be determined. The short reaction time for the acidolysis of the 2,4dimethoxybenzyl protecting group demonstrates the highly acid labile nature of the
newly developed thiouracil protecting group, however kinetic studies of the existing 4methoxybenzyl protecting group suggest that protection of the thiouracil nucleobase is
not necessary during PNA oligomerization.
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Figure 3.2. Relative 1H integration of benzylic protons of S-(2-methyl-4methoxybenzyl)thiouracil, S-(4-methoxybenzyl)thiouracil, and S-(4methoxybenzyl)thiothymine, over time.
The change in the benzylic integration over time was plotted to fit a first order
reaction curve with the natural logarithm of the benzylic proton integration against the
reaction time. The linear trend of the graph suggests the kinetics of the acidolysis reaction
as a first order reaction, dependent on the rate of decomposition of the protonated
nucleobase. Upon treatment of the nucleobase with the TFA solution, the acid-base
reaction occurs quickly resulting in the protonation of the nucleobase. Protonation of the
nucleobase occurs rabidly, with the rate limiting step being the decomposition of the
protonated nucleobase resulting in the cleavage of the thioether. From the first order
reaction plots, the half-life of the reaction is calculated to compare the relative rate of
acidolysis of the benzyl based protecting groups.
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A first order reaction proceeds dependent linearly on the concentration of a single
reactant (Eq. 1), so the equation for the rate is expressed as:

𝑟𝑎𝑡𝑒 = −

𝑑[𝐴]
= 𝑘[𝐴]
𝑑𝑡

(1)
Where the rate of the reaction is the change in concentration of the reactants over time,
which for a first order, unimolecular reaction is dependent on the concentration of a
single reactant ([𝐴]), and a rate constant (𝑘). The integration of the first order rate
equation (Eq. 1) yields a linear equation (Eq. 4) with respect to the natural logarithm of
the concentration of the reactant.
[𝐴]

𝑡
𝑑[𝐴]
∫
= ∫ −𝑘𝑑𝑡
[𝐴]𝑜 [𝐴]
𝑡𝑜

(2)
ln[𝐴] − ln[𝐴]𝑜 = −𝑘𝑡
(3)
ln[𝐴] = ln[𝐴]𝑜 − 𝑘𝑡
(4)
The integration of the benzylic protons is used as the concentration of the reactant and
the natural logarithm of the integration plotted with time yields a linear first order rate,
with the slope of the plot as the rate constant (Figure 3.3.). Using the rate constant, the
half-life of the acidolysis of the benzyl based protecting groups is calculated to compare
the relative stability of the protecting groups to deprotecting conditions.
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Figure 3.3. First order reaction curves for a) S-(4-methoxybenzyl)thiouracil, b) S-(4methoxybenzyl)thiothymine, and c) S-(2-methyl-4-methoxybenzyl)thiouracil treated with TFA
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Solving equation 4 for the half-life of the reaction, the time is calculated for half the initial
concentration (Eq. 6, Table 3.1).
−𝑘𝑡1
1
=𝑒 2
2

(5)

ln 2
𝑡1 = −
𝑘
2
(6)
Table 3.1. Half-life of acidolysis of benzyl based protecting groups of thiouracil and
thiothymine nucleobases
Protecting group
Nucleobase
Rate constant (k)
Half-life (𝒕𝟏/𝟐 )
(min)
S
4-methoxybenzyl
U
0.0111
62
ST
4-methoxybenzyl
0.0070
99
S
2-methyl-4-methoxybenzyl
U
0.0527
13
S
2,4-dimethoxybenzyl
U
<1
The acidolysis of the benzyl based protecting groups of thiouracil and thiothymine
demonstrated the highly acid-labile nature of the newly synthesized 2,4-dimethoxybenzyl
protected thiouracil nucleobase. This protecting group was rapidly removed under
treatment with mild TFA conditions, demonstrating a high sensitivity to deprotecting
conditions. Furthermore, this study demonstrated the previously unstudied acid-lability
of the 2-methyl-4-methoxybenzyl and 4-methoxybenzyl protecting previously developed
for the synthesis of thiouracil PNA monomers. The unexpected acidolysis of the 4methoxybenzyl protecting group suggests the protecting group is removed under
standard boc-based oligomerization conditions, thus the thiol protection is likely
unnecessary for oligomerization. To test this hypothesis, oligomerization was performed
using an unprotected thiouracil PNA monomer and compared to previous oligomerization
conditions.
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3.3. Synthesis of pcPNA oligomers
The pcPNA oligomers were synthesized using standard fmoc-based solid phase
peptide synthesis conditions. A series of 10-mer PNA oligomers were synthesized with the
sequence NH2-Lys-GXAGAXCACX-Lys-OH, where either the unmodified thymine PNA
monomer, or the novel thiouracil or thiothymine PNA monomers were used in the
synthesis of the 10-mer sequences. The PNA oligomers were synthesized on a polystyrene
resin with a Rink amide linker (Figure 3.4). The polystyrene resin provides an insoluble
support on which the PNA is oligomerizes which allows easy synthesis. The solid support
allows the oligomer to be isolated by filtration and excess reagent is easily washed with
dimethylformamide

and

dichloromethane.

Washing

the

solid

support

with

dichloromethane swells the resin, while washing with dimethylformamide contracts the
resin. Alternating washes of dimethylformamide and dichloromethane results in a
swelling and contracting of the resin which washes excess reagents through the
polystyrene resin. The polystyrene resin is functionalized with Rink amide linkers to which
the C-terminus of the peptide is attached. The Rink amide linker was developed as a more
acid labile linker, compared to the Merrifield linker (Figure 3.4), which allows the oligomer
to be removed from the polystyrene resin under treatment with milder acidic conditions.
Linkers originally developed for boc-based peptide synthesis required stronger acidic
conditions to remove the oligomer, as the linkage had to be resistant to treatment with
TFA used for boc deprotection.
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Figure 3.4. Merrifield linker and Rink amide linker
Prior to automated oligomerization the polystyrene resin is preloaded with Nαfmoc-Nε-boc-Lysine residue using HBTU and DIPEA as coupling agents to couple the Cterminus of the lysine to the Rink amide linker. Uncoupled linkers are capped using acetic
anhydride to prevent additional coupling to the linker during oligomerization. Automated
oligomerization is then carried out on the preloaded resin (K-PS) from the C-terminus to
the N-terminus of the peptide using commercially available fmoc/bhoc protected PNA
monomer and newly synthesized SU or ST PNA monomers. The FastMoc oligomerization
procedure first uses a solution of 20 % 4-methylpiperidine to remove the N-terminal fmoc
protecting group. The deprotection removal of the fmoc group results in the formation of
dibenzofulvene piperidine adduct and piperidine-carbamate salt (Figure 3.5.), which are
washed away with excess reagent. The deprotection of the terminal amine is monitored
by conductivity monitoring, which detects conductivity resulting from the presence of the
carbamate salt during deprotection. The prepared PNA monomers are mixed with a
solution of HBTU and DIPEA to form an active ester on the C-terminus of the monomer.
The activated PNA monomer is then mixed with the resin bound oligomer with the
unprotected N-terminus to grow the oligomer strand. The N-terminus of the unreacted
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oligomers are capped using acetic anhydride to prevent the synthesis of oligomers with a
nucleotide deletion. Capping with the acetic anhydride truncates the oligomerization of
the PNA strand. The deprotection, oligomerization and capping are repeated with each
PNA monomer to synthesize the PNA strand. The PNA oligomer is cleaved from the
polystyrene resin and removal of the bhoc and benzyl based protecting group from the
nucleobases using a solution of 95 % TFA. The PNA oligomers were purified by highpressure liquid chromatography (HPLC), and the purified oligomers were characterized by
high-resolution mass spectrometry (Table 3.2).
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Figure 3.5. Byproducts of the cleavage of fmoc protecting group from N-terminus
To test the need for a protecting group on the thiouracil nucleobase during
oligomerization, a sample of the prepared thiouracil PNA monomer (SU(MMOB)) was
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deprotected prior to oligomerization. The SU(MMOB) monomer was treated with the 95
% TFA solution for deprotection of the thiouracil nucleobase to yield the fmoc-SU-AEGOH PNA monomer for oligomerization. The thiouracil monomer without a protecting
group on the nucleobase was then used for oligomerization under standard fmoc-based
oligomerization conditions. The synthesized oligomer was purified by HPLC. The success
of the oligomerization without a nucleobase protecting group was qualitatively analyzed
by comparing the chromatogram of the unpurified oligomer to the chromatogram of the
pcPNA oligomer synthesized using the SU(MMOB) monomer.
Table 3.2. Observed high-resolution mass of synthesized PNA oligomers
PNA

Protecting
group

PNA sequence

Molecular
formula

Calculated
[M+Na]+

Observed
[M+Na]+

PNA-T

None

KGTAGATCACTK

C120H159N61O33

3005.2536

3005.2551

PNA-SU

4methoxybenzyl
None

KGSUAGASUCACSUK

C117H153N61O30S3

3011.1382

3011.2430

KGSUAGASUCACSUK

C117H153N61O30S3

3011.1382

3011.2624

4methoxybenzyl

KGSTAGASTCACSTK

C120H159N61O30S3

1538.0874a

1538.0963a

PNA-SU
PNA-ST
a

Oligomer calculated and observed as the dicationic [M+2Na]2+
The mass spectra of the synthesized PNA oligomers closely correlates with the

calculated mass for the PNA oligomer. Additionally, mass signals were detected
corresponding to the calculated [M+2Na]2+ and [M+3Na]3+ masses for all oligomers. The
close correlation with the calculated masses suggests the complete synthesis of the PNA
oligomers. This indicates the successful incorporation of the novel PNA monomers into
the oligomer using standard fmoc-based oligomerization procedures. Additionally, using
the thiouracil monomer with no protecting group on the thiol resulted in the successful
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synthesis of the desired PNA oligomer. The mass of the oligomer synthesized without
nucleobase protecting group matched that of the oligomer synthesized with the
protected thiouracil nucleobase, while the HPLC chromatogram showed no significant
impurities

resulting

from

truncated

oligomers

during

oligomerization.

The

oligomerization demonstrated that the protecting group on the thiol of the nucleobase
was unnecessary for oligomerization.
3.4 Conclusions and future work
Studies of the deprotection rates of benzyl based protecting groups on the
thiouracil nucleobase demonstrated the successful synthesis of a highly acid labile
protecting group for fmoc-based synthesis of pcPNA oligomers. The addition of electron
donating groups to the benzyl group stabilizes the benzylic carbocation resulting from the
acidolysis of the thioether. Stabilizing the carbocation intermediate allows cleavage of the
protecting group under milder acidic conditions. In addition to confirming the cleavage of
the novel thiouracil protecting group under standard deprotection conditions, the study
of the acidolysis discovered the cleavage of the previously synthesized 4-methoxybenzyl
protecting group, used for boc-based oligomerization, under standard boc deprotection
conditions. This suggested that a protecting group on the thiol was not necessary for PNA
oligomerization.
The novel thiouracil and thiothymine PNA monomers were incorporated into PNA
oligomers using standard fmoc-based oligomerization procedures. Characterization of the
oligomers by mass spectrometry demonstrates the successful incorporation of the novel
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thiouracil and thiothymine monomers into the PNA oligomer using standard fmoc-based
oligomerization. Furthermore, the PNA oligomers were synthesized using thiouracil
monomers without nucleobase protection, demonstrating the thiol protecting group is
only necessary for directing alkylation to the N-1 position and is not necessary for
oligomerization.
Future work will aim to test the stability of the synthesized PNA oligomer
hybridization with complementary PNA and DNA oligomers. Hybridizing the PNA
oligomers with a complementary target oligomer, then heating the duplex to determine
the melting temperature of the duplex can be used to determine the stability of the PNAPNA and PNA-DNA duplexes. Comparing the melting temperature of the thiouracil PNA
monomer with the thiothymine PNA monomer can be used to determine the effect of
replacing the thiouracil nucleobase with the thiothymine nucleobase on the stability of
the PNA hybridization. Further future work will aim to develop a more effective synthesis
of the fmoc-SU-AEG-OH monomer. The synthesis of the PNA oligomer using the
unprotected thiouracil nucleobase demonstrated the thiol group does not need
protecting during oligomerization. Therefore, a more effective monomer synthesis could
use a fmoc-AEG-Otbutyl backbone rather than the fmoc-AEG-Omethyl backbone. The
tbutyl

ester protection of the C-terminus is removed under acidic conditions, rather than

the basic conditions necessary for removal of the methyl ester protecting group. This is
orthogonal to the fmoc deprotection conditions and would prevent unwanted
deprotection of the N-terminus during ester hydrolysis. The acidic conditions would
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remove the protecting group from both the nucleobase and the C-terminus, yielding the
PNA monomer for oligomerization.
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Chapter 4: Experimental Procedures

Scheme 4.1. Attempted synthesis of methyl 2-((2-((2,4,6trimethoxybenzyl)thio)pyrimidin-4-yl)oxy)acetate
2,4,6-Trimethoxybenzyl alcohol (8)

To a solution of 2,4,6-trimethoxybenzaldehyde (1.00 g, 5.10 mmol) and 0.5 M
sodium hydroxide in methanol (30 mL) was added sodium borohydride (290 mg, 7.65
mmol) portionwise. The resultant solution was stirred for 2 h, then the reaction was
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quenched with 30 mL water. The solution was concentrated under reduced pressure to
approximately 30 mL, then the product was extracted into ether (3 x 20 mL). The organic
layers were combined, washed with brine, dried over sodium sulfate, then the solvent
evaporated to yield a clear, colourless oil which crystallized overnight (830 mg, 4.19
mmol, 82%). 1H NMR (400 MHz, CDCl3) δ 6.12 (s, 2H), 4.71 (s, 1H), 4.69 (s, 1H), 3.82 (s,
6H), 3.81 (s, 3H). This conformed closely with the 1H NMR spectrum previously reported
in the literature.1
2-(2,4,6-Trimethoxy-3-chlorobenzyl)thiouracil (10)

To a solution of 8 (2.00 g, 10.1 mmol) and triphenyl phosphine (1.94 g, 15.1 mmol)
in 100 mL dichloromethane at 0 oC, was added N-chlorosuccinimide (1.62mg, 12.1 mmol).
The solution was stirred for 1 h., then added to a suspension of 2-thiouracil (1.29 g, 10.1
mmol) and sodium carbonate (2.79 g, 20.2 mmol) in 100 mL dimethylformamide. The
mixture was stirred for 90 min., then neutralized with 40 mL saturated citric acid. The
solution was diluted with 150 mL water, then extracted in ethyl acetate (3 x 150 mL). The
organic layers were combined, washed with water (4 x 150 mL), and brine (150 mL), dried
over sodium sulfate, then the solvent was evaporated under reduced pressure to yielded
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crude compound 10 combined with triphenylphosphine oxide as an off white solid (2.55
g). The crude product was used for further synthesis.
Methyl 2-((2-((2,4,6-trimethoxy-3-chlorobenzyl)thio)pyrimidin-4-yl)oxy)acetate (11)

To a solution of crude 10 (2.55 g) and sodium carbonate (2.03 g, 11.1 mmol) in 120
mL dimethylformamide at 0 oC was added methyl bromoacetate (1.05 mL, 11.1 mmol),
then the reaction was stirred at 0 oC for 15 min, then allowed to warmed to room
temperature. The reaction was stirred for 4 h, then diluted with water (200 mL) and
extracted with ethyl acetate (3 x 120 mL). The organic layers were combined, washed with
water (4 x 100 mL) and brine (100 mL), dried with sodium sulfate, filtered, then the solvent
was evaporated under reduced pressure, yielding a crude orange oil (3.84 g). The crude
product was purified by column chromatography on silica gel (1:9 to 1:1 ethyl acetate:
hexanes) to yield the pure product as light-yellow crystals (234 mg, 0.56 mmol, 5.6 % from
(8)). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 5.7 Hz, 1H), 6.48 (d, J = 5.7 Hz, 1H), 6.27 (s,
1H), 4.89 (s, 2H), 4.37 (s, 2H), 3.85 (s, 3H), 3.82 (s, 3H), 3.79 (s, 3H), 3.71 (s, 3H). 13C NMR
(400 MHz, CDCl3) δ 172.2, 168.7, 167.5, 157.9, 157.7, 156.3, 156.0, 111.5, 108.6, 103.4,
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92.6, 62.5, 61.8, 56.4, 56.1, 52.3, 24.7. LRMS (EI) calculated for C17H19ClN2O6S [M]+ 414.07,
found 414.09.

Scheme 4.2. Synthesis of methyl 2-(2-((2,4-dimethoxybenzyl)thio)-4-oxopyrimidin-1(4H)yl)acetate (16a)
2,4-Dimethoxybenzyl alcohol (13)

To a solution of 2,4-dimethoxybenzaldehyde (5.00 g, 30.09 mmol) and 0.5 M
sodium hydroxide in 200 mL methanol was added sodium borohydride (1.37 g, 36.11
mmol) portionwise. The solution was stirred for 1 h, then the reaction was quenched with
water. The solution was concentrated under reduced pressure, then the product was
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extracted into ether. The organic layers were combined, washed with brine, dried over
sodium sulfate, filtered, then the solvent was evaporated under reduced pressure to yield
13 as a clear, colourless oil which crystalized overnight (4.45 g, 26.46 mmol, 88 %). 1H
NMR (400 MHz, CDCl3) δ 7.18 (d, J = 8.0 Hz, 1H), 6.52-6.42 (m, 2H), 4.63 (s, 2H), 3.86 (s,
3H), 3.82 (s, 3H), 2.27 (s, 1H).

13C

NMR (400 MHz, CDCl3) δ 160.7, 158.6, 129.7, 121.8,

103.9, 98.6, 61.7, 55.4, 55.3.
2-(2,4-Dimethoxybenzyl)thiouracil (15)

A solution of 2,4-dimethoxybenzyl alcohol (13) (4.12 g, 24.5 mmol) and pyridine
(3.95 mL, 49.0 mmol) in 50 mL dry ether was cooled to 0 oC, then thionyl chloride (4.89
mL, 67.4 mmol) was added dropwise to solution over 15 min. The solution was stirred for
90 min at 0 oC, then quenched with 50 mL ice cold water. The ethereal layer was collected,
and the aqueous layer was extracted with ether (3 x 25 mL). The organic layers were
combined, washed with water (50 mL), and 5:1 saturated sodium chloride: saturated
sodium bicarbonate (3 x 60 mL), and then dried over sodium sulfate. Dimethylformamide
(10 mL) was added to solution, then the ether was evaporated under reduced pressure.
The resulting dimethylformamide solution was added dropwise to a solution of 2thiouracil (1) (1.57 g, 12.26 mmol) and triethylamine (2.05 mL, 14.71 mmol) in 50 mL
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dimethylformamide at 0 oC. The resultant solution was stirred for 4 h at 0 oC, then diluted
with water and extracted with dichloromethane (3 x 40 mL). The dichloromethane layers
were combined, washed with water (4 x 50 mL), and brine (50 mL), dried over sodium
sulfate then the solvent was evaporated under reduced pressure. The resulting white
power was triturated with cold ether, yielding 14 as a pure white solid (2.41 g, 8.66, 71
%). 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 6.6 Hz, 1H), 7.31 (d, J = 8.2 Hz, 1H), 6.49-6.40
(m, 2H), 6.20 (d, J = 6.6 Hz, 1H), 4.42 (s, 2H), 3.86 (s, 3H), 3.81 (s, 3H). 13C NMR (400 MHz,
CDCl3) δ 164.4, 162.6, 160.9, 158.4, 154.8, 131.4, 116.6, 110.8, 104.3, 98.5, 55.5, 55.4,
29.7. HRMS (EI) calculated for C13H14N2O3S [M]+ 278.0725, found 278.0720.
Methyl 2-((2-((2,4-dimethoxybenzyl)thio)pyrimidin-4-yl)oxy)acetate (16b)

To a solution of 14 (1.00 g, 3.59 mmol) and sodium carbonate (1.24 g, 8.98 mmol)
in 60 mL dimethylformamide was added methyl bromoacetate (0.52 mL, 5.39 mmol) then
the solution was heated to 80 oC. The reaction was stirred for 2 h at 80 oC, then diluted
with water (70 mL) and extracted with dichloromethane (4 x 50 mL). The dichloromethane
layers were combined, washed with water (4 x 60 mL) and brine (60 mL), dried over
sodium sulfate, filtered, then the solvent was evaporated under reduced pressure,
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yielding a yellow solid (1.23 g, 3.37 mmol, 94%). 1H NMR (400 MHz, CDCl3) δ 8.31 (d, J =
5.7 Hz, 1H), 7.31 (d, J = 8.2 Hz, 1H), 6.55 (d, J = 5.7 Hz, 1H), 6.50-6.40 (m, 2H), 4.93 (s, 2H),
4.34 (s, 2H), 3.86 (s, 3H), 3.81 (s, 3H), 3.78 (s, 3H).

13C

NMR (400 MHz, CDCl3) δ 172.0,

168.6, 167.5, 160.4, 158.6, 157.8, 130.8, 117.6, 104.1, 103.5, 98.6, 62.4, 55.5, 55.4, 52.2,
29.7.
Methyl 2-(2-((2,4-dimethoxybenzyl)thio)-4-oxopyrimidin-1(4H)-yl)acetate (16a)

To a solution of sodium (165 mg, 7.18 mmol) in 15 mL methanol was added 7 (1.00
g, 3.59 mmol), then the solution was stirred and heated to reflux. Methyl bromoacetate
(0.79 mL, 7.18 mmol) was added to the reaction, the solution was stirred for 2 h at reflux,
then cooled to room temperature and the solvent was evaporated under reduced
pressure. The resulting residue was dissolved in 25 mL water then extracted with a
solution of 3:1 dichloromethane: methanol (2 x 80 mL). The organic layers were
combined, dried over sodium sulfate, filtered, then the solvent was evaporated under
reduced pressure to yield a white residue. The residue was purified by column
chromatography on silica gel (for 15, 1% methanol in dichloromethane; for 16a, 5%
methanol in dichloromethane to 10% methanol in dichloromethane), yielding 16a as a
pure white solid (289 mg, 0.79 mmol, 22 %). 1H NMR (400 MHz, CDCl3) δ 7.34 (d, J = 8.9
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Hz, 1H), 7.07 (d, J = 7.6 Hz, 1H), 6.41-6.34 (m, 2H), 6.02 (d, J = 7.6 Hz, 1H), 4.47 (s, 2H),
4.44 (s, 2H), 3.77 (s, 3H), 3.74 (s, 3H), 3.73 (s, 3H).

13C

NMR (400 MHz, CDCl3) δ 167.8,

166.4, 163.8, 160.9, 158.6, 143.6, 131.8, 115.9, 110.0, 104.1, 98.5, 55.3, 53.1, 52.6, 41.9,
31.3. HRMS (EI) calculated for C16H18N2O5S [M]+ 350.0936, found 350.0949.

Scheme 4.3. Synthesis of ethyl 2-(2-((2-methyl-4-methoxybenzyl)thio)-4-oxopyrimidin1(4H)-yl)acetate (21)
2-Methyl-4-methoxybenzyl alcohol (18)

To a solution of 2-methyl-4-methoxybenzaldehyde (2.03 g, 12.8 mmol) in 32 mL
ethanol was added sodium borohydride (519 mg, 13.7 mmol). The resultant solution was
stirred for 15 min., then the reaction was quenched by the addition of 240 mL water. The
solution was acidified with 4 M hydrochloric acid, then the product was extracted in
diethyl ether (3 x 80 mL). The ethereal layers were combined, washed with water (60 mL),
and brine (60 mL), then dried over sodium sulfate. The solvent was evaporated under
reduced pressure to yield the pure product as a clear, colourless oil (2.00 g, 12.8 mmol).
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1H

NMR (400 MHz, CDCl3) δ 7.19 (d, 1H, J = 8.3 Hz), 6.71 (d, 1H, J = 2.7 Hz), 6.68 (dd, 1H, J

= 2.7, 8.3 Hz), 4.59 (s, 2H), 3.76 (s, 3H), 2.33 (s, 3H), 1.59 (s, 1H). This closely corresponded
to the 1H NMR spectrum previously reported in the literature.2
2-(2-Methyl-4-methoxybenzyl)thiouracil (20)

To a solution of 2-methyl-4-methoxybenzyl alcohol (2.00 g, 12.8 mmol) in 80 mL
dry dichloromethane at 0 oC was added thionyl chloride (1.05 mL, 14.4 mmol) dropwise,
then the solution was stirred for 2 h at 0 oC. The reaction was added to a solution of ice
cold saturated sodium bicarbonate (250 mL), the dichloromethane layer was separated,
then the aqueous layer was extracted with diethyl ether (2 x 60 mL). The organic layers
were combined, washed with water (80 mL), and brine (80 mL), then dried over sodium
sulfate. The solvent was evaporated under reduced pressure to yield a clear colourless
oil. The resulting oil was dissolved 8 mL ethanol then added to a solution of 2-thouracil
(833 mg, 6.58 mmol) in 8 mL ethanol and 8 mL aqueous potassium hydroxide (474 mg,
4.45 mmol KOH in H2O). The resultant reaction was stirred overnight at room
temperature, then the solvent was evaporated under reduced pressure. A solution of
saturated sodium bicarbonate (20 mL) was added to the resultant residue then the
precipitate was collected by filtration, washed with water, ethanol, ethyl acetate, and
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diethyl ether to yield the product as pure white crystals (1.49 g, 5.60 mmol, 86 %). 1H
NMR (400 MHz, DMSO-d6) δ 7.29 (d, 1H, J = 8.3 Hz), 6.79 (d, 1H, J = 2.1 Hz), 6.72 (dd, 1H,
J = 2.1 Hz, 8.3 Hz), 4.35 (s, 2H), 3.72 (s, 3H), 2.32 (s, 3H). This closely corresponded to the
1H

NMR spectrum previously reported in the literature.2

Ethyl 2-(2-((2-methyl-4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)-yl)acetate (21)

To a solution of sodium (273 mg, 11.4 mmol) dissolved in ethanol (13 mL) was
added 2-(2-methyl-4-methoxybenzyl)thiouracil (1.49 g, 5.60 mmol). The resultant
suspension was stirred and heated to reflux until the solids dissolved, then ethyl
bromoacetate (1.26 mL, 11.4 mmol) was added dropwise, then the solution was stirred
at reflux for 2 h. The mixture was cooled to room temperature, then the ethanol was
evaporated under reduced pressure. Water (15 mL) was added to the resulting residue,
and the product was extracted in a solution of 3:1 dichloromethane: methanol (2 x 60
mL). The organic layers were combined, dried over sodium sulfate, then evaporated
under reduced pressure. The resultant residue was purified by column chromatography
on silica gel (ethyl acetate to 9:1 ethyl acetate: methanol) to yield the product as a pure
white solid (781 mg, 2.2 mmol, 40 %). 1H NMR (400 MHz, CDCl3) δ 7.25 (d, 1H, J = 8.2 Hz),
7.08 (d, 1H, J = 7.6 Hz), 6.69 (d, 1H, J = 2.6 Hz), 6.66 (dd, 1H, J = 2.6, 8.2 Hz), 6.08 (d, 1H, J
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= 7.6 Hz), 4.45 (s, 2H), 4.44 (s, 2H), 4.20 (q, 2H, J = 7.1 Hz), 3.74 (s, 3H), 2.30 (s, 3H), 1.23
(t, 3H, J = 7.1 Hz). This corresponded closely to the 1H NMR spectrum previously reported
in the literature.2

Scheme 4.4. Synthesis of ethyl 2-(2-((4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)yl)acetate (3)
4-Methoxybenzyl alcohol (23)

To a solution of 4-methoxybenzaldehyde (7.00 g, 51.4 mmol) in 60 mL ethanol was
added sodium borohydride (2.92 g, 77.1 mmol). The resultant solution was stirred for 30
min, then the reaction was quenched by the addition of 250 mL water. The solution was
acidified with 4 M hydrochloric acid, then the product was extracted into diethyl ether (3
x 100 mL). The ethereal layers were combined, washed with water (80 mL), and brine (80
mL), then dried over sodium sulfate. The solvent was evaporated under reduced pressure
to yield the pure product as a clear, colourless oil (6.93 g, 50.1 mmol, 97 %). 1H NMR (400
68

MHz, CDCl3) δ 7.27 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 8.4 Hz, 2H), 4.58 (s, 2H), 3.77 (s, 3H),
1.61 (br s, 1H). This closely corresponded to the 1H NMR spectrum previously reported in
the literature.3
2-(4-Methoxybenzyl)thiouracil (2)

To a solution of 4-methoxybenzyl alcohol (6.93 g, 50.1 mmol) in 150 mL dry
dichloromethane at 0 oC was added thionyl chloride (4.11 mL, 56.4 mmol) dropwise, then
the solution stirred at 0 oC. After 2 h., the reaction was added to a solution of ice cold
saturated sodium bicarbonate (300 mL), the dichloromethane layer was separated and
the aqueous layer was extracted with diethyl ether (2 x 100 mL). The organic layers were
combined, washed with water (120 mL), and brine (120 mL), then dried over sodium
sulfate. The solvent was evaporated under reduced pressure to yield a clear colourless
oil. The resultant oil was dissolved in 15 mL ethanol and then added to a solution of 2thouracil (5.77 g, 45.8 mmol) in 15 mL ethanol and 15 mL aqueous potassium hydroxide
(3.34 g, 56.5 mmol KOH in H2O). The resultant reaction was stirred overnight at room
temperature, then the solvent was evaporated under reduced pressure. A solution of
saturated sodium bicarbonate (50 mL) was added to the resultant residue, then the
precipitate was collected by filtration, washed with water, ethanol, ethyl acetate, and
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diethyl ether to yield the product as pure white crystals (5.61 g, 22.6 mmol, 50 %). 1H
NMR (400 MHz, DMSO-d6) δ 11.69 (br s, 1H), 7.88 (d, J = 6.6 Hz, 1H), 7.32 (d, J = 8.7 Hz,
2H), 6.86 (d, J = 8.7 Hz, 2H), 6.22 (d, J = 6.6 Hz, 1H), 4.42 (s, 2H), 3.81 (s, 3H). This
corresponded closely with the 1H NMR spectrum previously reported in the literature.3
Ethyl 2-(2-((4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)-yl)acetate (3)

To a solution of refluxing ethanol 80 mL was dissolved sodium (370 mg, 16.1
mmol), then S-(4-methoxybenzyl)thiouracil (2) (3.34 g, 13.4 mmol) was added to the
solution. Once the 2-(4-methoxybenzyl)thiouracil dissolved, ethyl bromoacetate (1.78
mL, 16.1 mmol) was added dropwise to the solution, and reaction was stirred at reflux for
90 min. The reaction was evaporated to dryness, then water was added to the residue
(100 mL). The aqueous solution was extracted with a solution of 3:1 dichloromethane:
methanol (2 x 200 mL). The organic layers were combined, dried over sodium sulfate,
filtered, then evaporated to dryness under reduced pressure. The resultant residue was
taken up into a solution of 1:1 ethyl acetate: hexanes, the solvent was evaporated under
reduced pressure, and the resulting residue was triturated with ice cold ethyl acetate to
yield the pure product as a white solid (712 mg, 2.12 mmol, 16 %). 1H NMR (400 MHz,
CDCl3) δ 7.34 (d, J = 8.6 Hz, 2H), 7.11 (d, J = 7.6 Hz, 1H), 6.87 (d, J = 8.6 Hz, 2H), 6.13 (d, J
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= 7.6 Hz, 1H), 4.504 (s, 2H), 4.499 (s, 2H), 4.28 (q, J = 7.2 Hz, 2H), 3.81 (s, 3H), 1.29 (t, J =
7.2 Hz, 3H). This closely corresponded with the 1H NMR spectra previously reported in the
literature.3
Thioester acidolysis
To a solution of 0.02 mL trifluoroacetic acid, 0.02 mL triethylsilane and 0.96 mL
deuterated chloroform was added to 3 mg of protected thiouracil or thiothymine (3, 16a,
21, 32) and the reaction was monitored by 1H NMR at 2 min. intervals until the reaction
was completed. The reaction was carried out at 25 OC and monitored for 2 h, or until
reaction had gone to completion. Integration of benzylic protons was monitored to
determine the rate of deprotection.
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Scheme 4.5. Synthesis of 2-(2-((4-methoxybenzyl)thio)-5-methyl-4-oxo-3,4dihydropyrimidin-1(2H)-yl)acetic acid (33)
1,3-Dimethylthymine (26)

To a solution of sodium hydroxide (9.5 g, 237.9 mmol) and thymine (5.00 g, 39.6
mmol) in a solution of 20 mL water was added dimethyl sulfate (18.8 mL, 198.2 mmol)
dropwise over 30 min. The solution was stirred for 2 h. until the starting material was
consumed. The solution was extracted with dichloromethane (3 x 150 mL), the organic
layers were combined, dried over sodium sulfate, filtered, then the solvent evaporated
under reduced pressure to yield a white solid (5.1 g, 33.1 mmol, 84 %). 1H NMR (400 MHz,
DMSO-d6) δ 7.58 (s, 1 H), 3.33 (s, 3 H), 3.27 (s, 3 H), 1.80 (s, 3 H). This closely corresponded
to the 1H NMR spectrum previously reported in the literature.4
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Thiothymine (27)

To a solution of sodium (2.7 g, 115.8 mmol) in 80 mL ethanol was added 1,3dimethylthymine (5.1 g, 33.1 mmol) and thiourea (10.1 g, 132.3 mmol). The solution was
stirred at reflux for 48 h., then the solvent was evaporated under reduced pressure. The
resultant residue was dissolved in 30 mL water and acidified with concentrated
hydrochloric acid. The precipitated was collected by filtration, yielding a pure white solid
(1.6 g, 11.3 mmol, 34 %). 1H NMR (400 MHz, DMSO-d6) δ 12.39 (s, 1H), 12.13 (s, 1H), 7.32
(s, 1H), 1.78 (s, 3H).

13C

NMR (400, DMSO-d6) δ 175.1, 162.4, 138.5, 114.3, 12.4. This

closely corresponded to the 1H NMR spectrum previously reported in the literature.5
2-(4-Methoxybenzyl)thiothymine (31)

To a solution of 25 mL ethanol was added thiothymine (1.00 g, 7.00 mmol)
followed by aqueous potassium hydroxide (510 mg, 9.10 mmol) in 15 mL water. The
solution was heated to 45 oC then 4-methoxybenzyl chloride (1.42 mL, 10.5 mmol) was
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added to the reaction. The reaction was stirred for 8 h., then evaporated to dryness under
reduced pressure. The resultant residue was suspended in a solution of 10 % sodium
bicarbonate (20 mL), then the precipitate was collected by filtration, and washed with
water, methanol, and diethyl ether to yield a pure white solid (1.3 g, 4.96 mmol, 71 %).
1H

NMR (400 MHz, DMSO-d6) δ 12.66 (br, 1H), 7.76 (s, 1H), 7.32 (d, J = 8.6 Hz, 2H), 6.87

(d, J = 8.6 Hz, 2H), 4.32 (s, 2H), 3.73 (s, 3H), 1.87 (s, 3H). HRMS (EI) calculated for
C13H14N2O2S [M]+ 262.0776, found 262.0770.
Ethyl

2-(2-((4-methoxybenzyl)thio)-5-methyl-4-oxo-3,4-dihydropyrimidin-1(2H)-

yl)acetate (32)

To a solution of sodium (210 mg, 9.15 mmol) in ethanol (15 mL) at reflux, was
added 2-(4-methyoxybenzyl)thiothymine (1.2 g, 4.57 mmol) followed by ethyl
bromoacetate (1.0 mL, 9.15 mmol). The reaction was stirred for 2 h. at reflux, then the
solvent was evaporated under reduced pressure. The residue was dissolved in water (15
mL) and extracted with a solution of 3:1 dichloromethane: methanol (2 x 60 mL). The
organic layers were combined, dried over sodium sulfate, and evaporated under reduced
pressure. The crude oil was washed with a solution of 1:1 ethyl acetate: hexanes (3 x 10
mL), the washes were combined and evaporated under reduced pressure. The resultant
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solid was suspended in ice cold ethyl acetate and the product was collected by filtration,
yielding a pure white solid (612 mg, 38 %). 1H NMR (400 MHz, DMSO-d6) δ 7.62 (s, 1 H),
7.34 (d, J = 8.7 Hz, 2 H), 6.88 (d, J = 8.7 Hz, 2 H), 4.76 (s, 2 H), 4.37 (s, 2 H), 4.17 (q, J = 7.1,
2 H), 3.73 (s, 3 H), 1.82 (s, 3 H), 1.18 (t, J = 7.1, 3 H). 13C NMR (400 MHz, DMSO) δ 167.9,
167.5, 159.2, 142.1, 130.9, 128.6, 117.4, 114.4, 62.2, 55.5, 52.8, 34.9, 14.4, 13.8. HRMS
(EI) calculate for C17H20N2O4S [M]+ 348.1144, found 348.1145.
2-(2-((4-Methoxybenzyl)thio)-5-methyl-4-oxo-3,4-dihydropyrimidin-1(2H)-yl)acetic
acid (33)

To a solution of 32 (250 mg, 0.72 mmol) dissolved in methanol (2.2 mL) and
tetrahydrofuran (5 mL) was added 0.72 mL of 2 M lithium hydroxide, then the solution
was stirred for 15 min. The solvent was evaporated under reduced pressure, then the
residue was dissolved in 5 mL water and the solution was acidified with 2 M hydrochloric
acid. The resultant precipitate was filtered and washed with cold ethyl acetate and diethyl
ether which yielded a pure white solid (185 mg, 0.38 mmol, 80 %). 1H NMR (400 MHz,
DMSO-d6) δ 13.53 (s, 1 H), 7.62 (s, 1 H), 7.34 (d, J = 8.4 Hz, 2 H), 6.88 (d, J = 8.4 Hz, 2 H),
4.64 (s, 2 H), 4.37 (s, 2 H), 3.73 (s, 2 H), 1.82 (s, 3 H). 13C NMR (400 MHz, DMSO) δ 168.9,
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167.9, 161.6, 159.1, 142.3, 130.9, 128.7, 117.5, 114.4, 55.6, 52.9, 34.8, 13.8. HRMS (EI)
calculated for C15H16N2O4S [M]+ 320.0831, found 320.0828.

Scheme 4.6. Synthesis of Fmoc-thiothymine PNA monomer (37)
Methyl-N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)glycinate
hydrochloride (35)

To a suspension of 34 (1.00 g, 4.87 mmol) and Fmoc-succinimide (1.80 g, 5.36
mmol) in 16 mL dioxane was added a solution of sodium bicarbonate (1.23 g, 14.61 mmol)
in 20 mL water, then the resulting solution was stirred for 50 min. The solution was diluted
with 60 mL water, then the white precipitate was extracted with dichloromethane (3 x 50
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mL). The dichloromethane layers were combined, dried over sodium sulfate, filtered, and
the resultant solution was acidified with ethereal hydrochloric acid. The solution was
cooled overnight and the resultant precipitate filtered to yield the product (35) as a pure
white solid (432 mg, 23 %). 1H NMR (400 MHz, DMSO-d6) δ 9.21 (br s, 2H), 7.90 (d, J = 7.5
Hz, 2H), 7.70 (d, J = 7.5 Hz, 2H), 7.54 (t, J = 5.1, 1H), 7.42 (t, J = 7.5 Hz, 2H), 7.34 (t, J = 7.5
Hz, 2H), 4.34 (d, J = 6.7 Hz, 2H), 4.23 (t, J = 6.8, 1H), 3.96 (s, 2H), 3.74 (s, 3H), 3.33
(overlapping with water), 3.00 (t, J = 6.4 Hz, 2H). 13C NMR (400 MHz, DMSO-d6) δ 167.9,
156.8, 144.3, 141.2, 128.1, 127.6, 125.6, 120.6, 66.1, 55.4, 53.0, 47.3, 47.1, 37.3. This
closely corresponded to 1H NMR spectra previously reported in the literature.6
Methyl-N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2-((4methoxybenzyl)thio)-5-methyl-4-oxopyrimidin-1(4H)-yl)acetyl) glycinate (36)

To a solution of 33 (280 mg, 0.87 mmol) in 7 mL dimethylformamide at 0 oC was
added HBTU (338 mg, 0.89 mmol) and diisopropylethylamine (0.48 mL, 1.55 mmol) and
stirred for 2 min., then 35 (375 mg, 0.96 mmol) was added to the reaction and the mixture
was stirred for 2 h., then allowed to warm to room temperature. The reaction mixture
was diluted with 15 mL ethyl acetate, poured into 40 mL water, then extracted with ethyl
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acetate (3 x 20 mL). The organic layers were combined, washed with 5 % citric acid in
water (20 mL), saturated sodium bicarbonate (20 mL), and brine (20 mL), then dried over
sodium sulfate, filtered, after which the solvent was evaporated under reduced pressure.
This yielded a crude orange oil which was purified by column chromatography on silica
gel (1 % methanol-dichloromethane to 5 % methanol-dichloromethane) to yield
compound 36 as a pure white solid (312 mg, 0.48mmol, 55 %) HRMS (ESI) calculated for
C35H36N4O7SNa [M+Na]+ 679.2202, found 679.2205.
N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2-((4methoxybenzyl)thio)-5-methyl-4-oxopyrimidin-1(4H)-yl)acetyl)glycine (37)

To a solution of 36 (312 mg, 0.48 mmol) in 8 mL tetrahydrofuran at 0 OC was added
8 mL 2 M lithium hydroxide then the solution was stirred for 30 min. The reaction was
neutralized with 2 M hydrochloric acid then the solvent was evaporated under reduced
pressure. The residue was suspended in 10 mL ice cold water and the resultant precipitate
was collected by filtration. The solid was suspended in cold dichloromethane, then the
product was collected by filtration to yield the PNA monomer (37) as a pure white solid
(126 mg, 20 mmol, 41 %) 1H NMR (400 MHz, DMSO-d6) δ 8.06 (m, 1H), 7.89 (d, J = , 2H),
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7.67 (m, 2H), 7.43-7.27 (m, 7H), 6.80 (d, J = , 2H), 4.70 (s, 2H), 4.28 (s, 2H), 4.16 (s, 2H),
3.69 (s, 3H), 3.64 (s, 2H), 3.59 (s, 1H), 3.38 (m, 2H), 3.15 (m, 2H), 1.73 (s, 3H). 13C NMR
(400 MHz, DMSO) δ 170.2, 168.2, 166.8, 162.0, 159.0, 156.5, 144.4, 142.5, 141.1, 130.8,
129.4, 128.8, 128.1, 127.8, 127.6, 125.9, 121.9, 120.5, 117.1, 114.3, 66.0, 55.5, 53.5, 53.0,
48.4, 47.2, 38.4, 34.9, 13.7. HRMS (ESI) calculated for C34H34N4O7SNa [M+Na]+ 665.2046,
found 665.2030.
Oligomer synthesis
The PNA oligomers were synthesized using an ABI 433A peptide synthesizer
manufactured by Perkin Elmer Applied Biosystems. Oligomerization was carried out using
newly synthesized SU and ST monomers, commercially available PNA monomers: FmocA(Bhoc)-AEG-OH, Fmoc-G(Bhoc)-AEG-OH, and Fmoc-C(Bhoc)-AEG-OH (purchased from
PolyOrg, Inc.), and Nα-Fmoc-Nε-Boc-Lysine (purchased from Chem-Impex Int’l Inc.), using
standard FastMoc oligomerization methods for Fmoc-based solid-phase peptide
synthesis. Fmoc-RAM-PS was used as a solid support resin preloaded with lysine at 0.057
mmol/g. Synthesis was carried out on a 5.0 μmol scale. Monomers were prepared at a
concentration of 25 μmol dissolved in 110 μL. Solutions of 0.4 M diisopropylethylamine
in N-methyl-2-pyrrolidone (NMP) and 0.19 M HBTU in NMP were prepared for monomer
coupling. Fmoc deprotection was performed using a solution of 20 % 4-methylpiperidine
in dimethylformamide. Unreacted terminal amino groups were capped with acetic
anhydride, using a solution of 1:25:25 acetic anhydride: pyridine: NMP. Following
automated synthesis, the resin was treated with a solution of 95 % trifluoroacetic acid
and 5 % triethylsilane to cleave the oligomer from the resin and remove the protecting
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group from the nucleobases (Bhoc) and amino group (Boc). The solvent was then
evaporated under a nitrogen stream, the resultant residue was washed twice with cold
ether, dissolved in a solution of 0.05% trifluoroacetic acid in water then purified by
reverse-phase HPLC. Reverse-phase HPLC was performed on an Agilent Microsorb-MV
100-5 C18 250 x 4.6 mm column heated to 50 oC. The purified PNA oligomer was eluted
using a gradient (water/0.1 % trifluoroacetic acid to acetonitrile/0.1 % trifluoroacetic acid)
over 60 min.

80

Appendix of Spectra

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

VITA

NAME:Timothy Martin-Chan
Post-Secondary Education
The University of Western Ontario
London, Ontario, Canada
B.Sc. Honors Biochemistry and Chemtry
2013-2016
The University of Western Ontario
London, Ontario, Canada
M.Sc. Chemistry
2016-2018
Related Work Experience
Teaching Assistant
Department of Chemistry, the University of Western Ontario
London, Ontario, Canada
2016-2018
Poster Presentations
Martin-Chan, Timothy and Hudson, Robert H.E. Synthesis of 2-thiouracil PNA for Fmocbased synthesis of pseudo-complementary oligomer. Presented at 100th Canadian
Chemistry Conference and Exhibition, Toronto, Canada, May 28-June 1, 2017.
Martin-Chan, Timothy; Park, Gyeongsu; El Samman, Amer; Hudson, Robert H.E. A
Chimeric Nucleobase – Phenylazo derivatives as an intrinsic nucleobase quencher.
Presented at 100th Canadian Chemistry Conference and Exhibition, Toronto, Canada,
May 28-June 1, 2017.

112

